Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 54 | 0 | 21 | 0 | €135.15 | €150.00 | 10.988% |
| Illumina Inc. | 44 | 6 | 20 | 2 | €106.42 | €140.00 | 31.554% |
| Abbott Laboratories | 38 | 0 | 18 | 0 | €95.59 | €109.09 | 14.128% |
| Stryker Corp. | 42 | 1 | 17 | 0 | €311.30 | €340.00 | 9.219% |
| Haemonetics Corp. | 26 | 0 | 16 | 0 | €81.50 | €98.20 | 20.492% |
| Intuitive Surgical Inc | 54 | 0 | 16 | 0 | €407.30 | €450.00 | 10.484% |
| EyePoint Pharmaceuticals Inc. | 37 | 1 | 15 | 0 | €9.48 | €23.89 | 152.068% |
| Biogen Inc. | 73 | 1 | 15 | 0 | €211.00 | €282.11 | 33.703% |
| Ani Pharmaceuticals Inc. | 18 | 1 | 15 | 0 | €59.50 | €69.75 | 17.227% |
| Pfizer Inc. | 50 | 4 | 15 | 0 | €26.52 | €33.45 | 26.146% |
| Merck & Co. Inc. | 49 | 1 | 15 | 0 | €117.20 | €125.66 | 7.217% |
| Intra-Cellular Therapies Inc. | 49 | 0 | 14 | 0 | €72.00 | €85.00 | 18.056% |
| UnitedHealth Group Inc. | 55 | 2 | 14 | 1 | €469.10 | €527.50 | 12.449% |
| Vertex Pharmaceuticals Inc. | 71 | 2 | 14 | 0 | €448.15 | €515.91 | 15.120% |
| Actinium Pharmaceuticals Inc. | 18 | 0 | 14 | 0 | €6.82 | €9.00 | 31.965% |
| Boston Scientific | 71 | 0 | 14 | 0 | €71.50 | €79.29 | 10.892% |
| Johnson & Johnson | 57 | 2 | 14 | 1 | €137.48 | €163.24 | 18.737% |
| Aldeyra Therapeutics Inc. | 16 | 0 | 14 | 0 | €3.14 | €5.38 | 71.451% |
| Exact Sciences | 30 | 0 | 12 | 0 | €42.53 | €55.00 | 29.336% |
| Dexcom Inc. | 35 | 0 | 12 | 0 | €104.60 | €120.50 | 15.201% |
| Aclaris Therapeutics Inc | 15 | 0 | 11 | 0 | €1.18 | €2.50 | 112.224% |
| Zoetis Inc. A | 35 | 1 | 11 | 0 | €164.20 | €181.79 | 10.713% |
| Amgen Inc. | 45 | 0 | 11 | 0 | €303.35 | €320.00 | 5.489% |
| Regeneron Pharmaceuticals Inc. | 62 | 1 | 11 | 0 | €1,009.0 | €1,072.3 | 6.270% |
| Sarepta Therapeutics | 20 | 0 | 11 | 0 | €139.40 | €180.00 | 29.125% |